[{"id":"36c50d4c-674c-49cc-b65b-465083462f63","acronym":"","url":"https://clinicaltrials.gov/study/NCT05965505","created_at":"2023-07-31T17:08:57.765Z","updated_at":"2024-07-02T16:35:40.164Z","phase":"Phase 1","brief_title":"Study of AXT-1003 in Adult Subjects With Relapsed/Refractory Non-Hodgkin Lymphomas","source_id_and_acronym":"NCT05965505","lead_sponsor":"Axter Therapeutics (Beijing) Co., Ltd","biomarkers":" ALK","pipe":" | ","alterations":" ALK positive • ALK negative","tags":["ALK"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e ALK positive • ALK negative"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e AXT-1003"],"overall_status":"Recruiting","enrollment":" Enrollment 79","initiation":"Initiation: 08/11/2023","start_date":" 08/11/2023","primary_txt":" Primary completion: 12/01/2025","primary_completion_date":" 12/01/2025","study_txt":" Completion: 01/01/2026","study_completion_date":" 01/01/2026","last_update_posted":"2023-08-14"}]